Skip to main content

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ADMA holding history

Adma Biologics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings

Shares (Q2 2026)
5,274,597
Value
$44.1M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of ADMA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,274,597$44.1M<0.1%+4,713,770+840.5%AddedHolders
Q1 2026560,827$5.05M<0.1%+3,674+0.7%AddedHolders
Q4 2025557,153$10.2M<0.1%+224,452+67.5%AddedHolders
Q3 2025332,701$4.88M<0.1%−499,862−60.0%ReducedHolders
Q2 2025832,563$15.2M<0.1%−692,964−45.4%ReducedHolders
Q1 20251,525,527$30.3M<0.1%−1,541,048−50.3%ReducedHolders
Q4 20243,066,575$52.6M0.1%−2,197,520−41.7%ReducedHolders
Q3 20245,264,095$105.2M0.1%−1,560,422−22.9%ReducedHolders
Q2 20246,824,517$76.3M0.1%+1,442,799+26.8%AddedHolders
Q1 20245,381,718$35.5M<0.1%−1,131,835−17.4%ReducedHolders
Q4 20236,513,553$29.4M<0.1%−1,058,140−14.0%ReducedHolders
Q3 20237,571,693$27.1M<0.1%−602,124−7.4%ReducedHolders
Q2 20238,173,817$30.2M<0.1%−37,756−0.5%ReducedHolders
Q1 20238,211,573$27.2M<0.1%−296,836−3.5%ReducedHolders
Q4 20228,508,409$33.0M0.1%+2,664,613+45.6%AddedHolders
Q3 20225,843,796$14.2M<0.1%+1,011,404+20.9%AddedHolders
Q2 20224,832,392$9.57M<0.1%+2,930,104+154.0%AddedHolders
Q1 20221,902,288$3.48M<0.1%+1,812,981+2,030.1%AddedHolders
Q4 202189,307$126.0K<0.1%+89,307NewHolders
Q3 20210$00.0%−211,692−100.0%Sold outHolders
Q2 2021211,692$339.0K<0.1%+211,692NewHolders